Recon: GSK nabs FDA authorization for expanded RSV jab indication; Mideast war disrupts region’s pharma supply chain

• GSK’s RSV Shot Wins Expanded US Approval Amid Vaccine Pressure (Bloomberg)
• Trump is getting more credit than Biden for efforts to lower drug prices (STAT)
• PDUFA VIII: US FDA Shared Services Unit Could Reduce User Fees (Pink Sheet)
• Genentech CEO says aiming for tolerable, affordable obesity drugs (Reuters)

• Middle East war disrupts pharma air routes, risks cancer drugs supply (Reuters)
• Baidu-Backed BioMap Is Said to Confidentially File for HK IPO (Bloomberg)
• Ozempic Patent Expiry Heralds Weight-Loss Drug Boom in India (Bloomberg)
• Supply Costs Jump For India’s Medical Device Makers As Middle East Conflict Disrupts Gas Supply (MedTech Insight)
• VBP, Reimbursement Cuts And Uncertain Outlook: How Medtech’s Biggest Players Are Reading China (MedTech Insight)
• EU Push To Streamline Clinical Trials Must Respect Privacy Rights, Say Data Watchdogs (Pink Sheet)
• French Health Care Professionals Warn Of Medicine Access Problems (Pink Sheet)

• Novartis Offers High-Grade Debt to Fund $12 billion Avidity Deal (Bloomberg)
• I have a genetic mutation linked to ALS. The Trump administration terrifies me (STAT)
• Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pill (STAT)
• BioMarin pumps brakes on 3 Voxzogo studies as competition in drug's flagship achondroplasia indication mounts (Fierce Pharma)

• A brain-computer interface allowed people with paralysis to type with their mind (STAT)
• Amplifon to Buy GN Store Nord Hearing Aid Unit for $2.6 Billion (Bloomberg)
• Intuitive Surgical hit by phishing incident (MedTech Dive)
• FDA Weight Loss Device Guidance Calls For Patient Focus (MedTech Insight)
• FDA And Industry To Move Forward On Commitment Letter After Agreeing On Several Proposals (MedTech Insight)

• Japan Prices New Products Including Milk Fortifier But Cuts Capivasertib Price 10.7% (Pink Sheet)
• USDA sued over state SNAP restrictions on candy, soda (Food Dive)

• New technologies promise to transform organ transplantation. But when? (STAT)
• Major changes to cardiovascular guidelines suggest taking statins as young as 30 (STAT)
• Congress must pass legislation to ensure Medicare covers breakthrough medical technologies (STAT)
• FDA move on flavored vapes rattles public health experts (STAT)
• Republicans Are Squandering Their MAHA Moment (Bloomberg)
• Trump’s EPA Eases Controls in Proposed Ethylene Oxide Rule (Bloomberg)